Cargando…

A Surface-Enhanced Raman Spectral Library of Important Drugs Associated With Point-of-Care and Field Applications

During the past decade, the ability of surface-enhanced Raman spectroscopy (SERS) to measure extremely low concentrations, such as mg/L and below, and the availability of hand-held Raman spectrometers, has led to a significant growth in the number and variety of applications of SERS to real-world pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Farquharson, Stuart, Brouillette, Carl, Smith, Wayne, Shende, Chetan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823623/
https://www.ncbi.nlm.nih.gov/pubmed/31709234
http://dx.doi.org/10.3389/fchem.2019.00706
_version_ 1783464570747092992
author Farquharson, Stuart
Brouillette, Carl
Smith, Wayne
Shende, Chetan
author_facet Farquharson, Stuart
Brouillette, Carl
Smith, Wayne
Shende, Chetan
author_sort Farquharson, Stuart
collection PubMed
description During the past decade, the ability of surface-enhanced Raman spectroscopy (SERS) to measure extremely low concentrations, such as mg/L and below, and the availability of hand-held Raman spectrometers, has led to a significant growth in the number and variety of applications of SERS to real-world problems. Most of these applications involve the measurement of drugs, such as quantifying medication in patients, identifying illicit drugs in impaired drivers, and more recently, identifying drugs used as weapons. Similar to Raman spectroscopy, most of the point-of-care and field applications involve the identification of the drug to determine the course of action. However, unlike Raman spectroscopy, spectral libraries are not readily available to perform the necessary identification. In a large part, this is due to the uniqueness of the commercially available SERS substrates, each of which can produce different spectra for the same drug. In an effort to overcome this limitation, we have measured numerous drugs using the most common, and readily available SERS material and hand-held Raman analyzers, specifically gold colloids and analyzers using 785 nm laser excitation. Here we present the spectra of some 39 drugs of current interest, such as buprenorphine, delta-9 tetrahydrocannabinol, and fentanyl, which we hope will aid in the development of current and future SERS drug analysis applications.
format Online
Article
Text
id pubmed-6823623
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68236232019-11-08 A Surface-Enhanced Raman Spectral Library of Important Drugs Associated With Point-of-Care and Field Applications Farquharson, Stuart Brouillette, Carl Smith, Wayne Shende, Chetan Front Chem Chemistry During the past decade, the ability of surface-enhanced Raman spectroscopy (SERS) to measure extremely low concentrations, such as mg/L and below, and the availability of hand-held Raman spectrometers, has led to a significant growth in the number and variety of applications of SERS to real-world problems. Most of these applications involve the measurement of drugs, such as quantifying medication in patients, identifying illicit drugs in impaired drivers, and more recently, identifying drugs used as weapons. Similar to Raman spectroscopy, most of the point-of-care and field applications involve the identification of the drug to determine the course of action. However, unlike Raman spectroscopy, spectral libraries are not readily available to perform the necessary identification. In a large part, this is due to the uniqueness of the commercially available SERS substrates, each of which can produce different spectra for the same drug. In an effort to overcome this limitation, we have measured numerous drugs using the most common, and readily available SERS material and hand-held Raman analyzers, specifically gold colloids and analyzers using 785 nm laser excitation. Here we present the spectra of some 39 drugs of current interest, such as buprenorphine, delta-9 tetrahydrocannabinol, and fentanyl, which we hope will aid in the development of current and future SERS drug analysis applications. Frontiers Media S.A. 2019-10-25 /pmc/articles/PMC6823623/ /pubmed/31709234 http://dx.doi.org/10.3389/fchem.2019.00706 Text en Copyright © 2019 Farquharson, Brouillette, Smith and Shende. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
Farquharson, Stuart
Brouillette, Carl
Smith, Wayne
Shende, Chetan
A Surface-Enhanced Raman Spectral Library of Important Drugs Associated With Point-of-Care and Field Applications
title A Surface-Enhanced Raman Spectral Library of Important Drugs Associated With Point-of-Care and Field Applications
title_full A Surface-Enhanced Raman Spectral Library of Important Drugs Associated With Point-of-Care and Field Applications
title_fullStr A Surface-Enhanced Raman Spectral Library of Important Drugs Associated With Point-of-Care and Field Applications
title_full_unstemmed A Surface-Enhanced Raman Spectral Library of Important Drugs Associated With Point-of-Care and Field Applications
title_short A Surface-Enhanced Raman Spectral Library of Important Drugs Associated With Point-of-Care and Field Applications
title_sort surface-enhanced raman spectral library of important drugs associated with point-of-care and field applications
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823623/
https://www.ncbi.nlm.nih.gov/pubmed/31709234
http://dx.doi.org/10.3389/fchem.2019.00706
work_keys_str_mv AT farquharsonstuart asurfaceenhancedramanspectrallibraryofimportantdrugsassociatedwithpointofcareandfieldapplications
AT brouillettecarl asurfaceenhancedramanspectrallibraryofimportantdrugsassociatedwithpointofcareandfieldapplications
AT smithwayne asurfaceenhancedramanspectrallibraryofimportantdrugsassociatedwithpointofcareandfieldapplications
AT shendechetan asurfaceenhancedramanspectrallibraryofimportantdrugsassociatedwithpointofcareandfieldapplications
AT farquharsonstuart surfaceenhancedramanspectrallibraryofimportantdrugsassociatedwithpointofcareandfieldapplications
AT brouillettecarl surfaceenhancedramanspectrallibraryofimportantdrugsassociatedwithpointofcareandfieldapplications
AT smithwayne surfaceenhancedramanspectrallibraryofimportantdrugsassociatedwithpointofcareandfieldapplications
AT shendechetan surfaceenhancedramanspectrallibraryofimportantdrugsassociatedwithpointofcareandfieldapplications